<DOC>
	<DOCNO>NCT00831454</DOCNO>
	<brief_summary>The aim study retrospectively evaluate association EGFR AKT DNA-polymorphisms involve transcriptional regulation overall survival NSCLC patient treat EGFR-TKIs .</brief_summary>
	<brief_title>Identification EGFR-TKIs Sensitivity Resistance Markers NSCLC May Help Optimal Patient Selection</brief_title>
	<detailed_description>DNA isolate blood sample paraffin-embedded tumor specimen mutation analysis SNPs genotyping do .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Availability tumor tissue blood sample . Diagnosis NSCLC At least one treatment EGFRTKIs inhibitors Other NSCLC primary diagnosis No treatment EGFRTKIs inhibitors No archival tissue available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>